CFDA approves Canbridge's oral mucositis drug

Canbridge Life Sciences Ltd. (Beijing, China) said China FDA approved Caphosol (CAN002) to treat oral mucositis.

The company has Chinese rights to the supersaturated calcium phosphate rinse from EUSA Pharma Ltd. (Hemel Hempstead, U.K.). The company said the drug, which is approved in 47 other countries, is its first commercialized product...